Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging

Biomaterials

Volumn 35, Issue 11, 2014, Pages 3666-3677

  Li, Jingchao ^a   He, Yao ^b   Sun, Wenjie ^a   Luo, Yu ^a   Cai, Hongdong ^a   Pan, Yunqi ^a   Shen, Mingwu ^a   Xia, Jindong ^b   Shi, Xiangyang ^a  

^a DONGHUA UNIVERSITY   (China)

^b Shanghai Songjiang District Central Hospital   (China)

Author keywords

Hyaluronic acid; Iron oxide nanoparticles; MR imaging; Polyethyleneimine; Targeting; Tumors

Indexed keywords

HYALURONIC ACID; IRON OXIDE NANOPARTICLES; MR IMAGING; POLYETHYLENEIMINE; TARGETING; TUMORS;

ANIMALS; CELL DEATH; CELL LINE, TUMOR; CELL SHAPE; CELL SURVIVAL; FERRIC COMPOUNDS; FLOW CYTOMETRY; FLUORESCENCE; HEMOLYSIS; HUMANS; HYALURONIC ACID; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; NEOPLASMS; PARTICLE SIZE; POLYETHYLENEIMINE; TEMPERATURE; THERMOGRAVIMETRY; WATER; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84894918989     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.01.011     Document Type: Article

References (71)

1. Koo Y.-E.L., Reddy G.R., Bhojani M., Schneider R., Philbert M.A., Rehemtulla A., et al. Brain cancer diagnosis and therapy with nanoplatforms. Adv Drug Deliv Rev 2006, 58:1556-1577.
2. Kopelman R., Lee Koo Y.-E., Philbert M., Moffat B.A., Ramachandra Reddy G., McConville P., et al. Multifunctional nanoparticle platforms for invivo MRI enhancement and photodynamic therapy of a rat brain cancer. JMagn Magn Mater 2005, 293:404-410.
3. Popovtzer R., Agrawal A., Kotov N.A., Popovtzer A., Balter J., Carey T.E., et al. Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano Lett 2008, 8:4593-4596.
4. Chen Y., Chen H., Zeng D., Tian Y., Chen F., Feng J., et al. Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery. ACS Nano 2010, 4:6001-6013.
5. 2 hollow mesoporous spheres as carriers for drug delivery. Small 2010, 6:471-478.
6. Pan B., Cui D., Sheng Y., Ozkan C., Gao F., He R., et al. Dendrimer-modified magnetic nanoparticles enhance efficiency of gene delivery system. Cancer Res 2007, 67:8156-8163.
7. 2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles. Biomaterials 2011, 32:4584-4593.
8. Shen M., Shi X. Dendrimer-based organic/inorganic hybrid nanoparticles in biomedical applications. Nanoscale 2010, 2:1596-1610.
9. Shi X., Thomas T.P., Myc L.A., Kotlyar A., Baker J.R. Synthesis, characterization, and intracellular uptake of carboxyl-terminated poly (amidoamine) dendrimer-stabilized iron oxide nanoparticles. Phys Chem Chem Phys 2007, 9:5712-5720.
10. Guo R., Shi X. Dendrimers in cancer therapeutics and diagnosis. Curr Drug Metab 2012, 13:1097-1109.
11. Cheng L., Yang K., Li Y., Zeng X., Shao M., Lee S.-T., et al. Multifunctional nanoparticles for upconversion luminescence/MR multimodal imaging and magnetically targeted photothermal therapy. Biomaterials 2012, 33:2215-2222.
12. Ma X., Tao H., Yang K., Feng L., Cheng L., Shi X., et al. Afunctionalized graphene oxide-iron oxide nanocomposite for magnetically targeted drug delivery, photothermal therapy, and magnetic resonance imaging. Nano Res 2012, 5:199-212.
13. 4 at Au nanocomposite particles for dual mode magnetic resonance and computed tomography imaging applications. JMater Chem 2012, 22:15110-15120.
14. 2 contrast agent for magnetic resonance imaging. JKorean Phys Soc 2010, 56:868-873.
15. Wang S.H., Shi X., Van Antwerp M., Cao Z., Swanson S.D., Bi X., et al. Dendrimer-functionalized iron oxide nanoparticles for specific targeting and imaging of cancer cells. Adv Funct Mater 2007, 17:3043-3050.
16. Shi X., Wang S.H., Swanson S.D., Ge S., Cao Z., Van Antwerp M.E., et al. Dendrimer-functionalized shell-crosslinked iron oxide nanoparticles for in-vivo magnetic resonance imaging of tumors. Adv Mater 2008, 20:1671-1678.
17. 3-rich tumor cells. JAm Chem Soc 2008, 130:7542-7543.
18. Narayanan S., Sathy B.N., Mony U., Koyakutty M., Nair S.V., Menon D. Biocompatible magnetite/gold nanohybrid contrast agents via green chemistry for MRI and CT bioimaging. ACS Appl Mater Interfaces 2011, 4:251-260.
19. Ji X., Shao R., Elliott A.M., Stafford R.J., Esparza-Coss E., Bankson J.A., et al. Bifunctional gold nanoshells with a superparamagnetic iron oxide-silica core suitable for both MR imaging and photothermal therapy. JPhys Chem C 2007, 111:6245-6251.
20. Strable E., Bulte J.W.M., Moskowitz B., Vivekanandan K., Allen M., Douglas T. Synthesis and characterization of soluble iron oxide-dendrimer composites. Chem Mater 2001, 13:2201-2209.
21. 4 magnetic nanoparticles for removal of Cu (II) ions. JColloid Interface Sci 2005, 283:446-451.
22. 4 composite nanoparticles in tiny pools of water-in-oil microemulsion. React Funct Polym 2006, 66:1552-1558.
23. Berry C.C., Wells S., Charles S., Aitchison G., Curtis A.S.G. Cell response to dextran-derivatised iron oxide nanoparticles post internalisation. Biomaterials 2004, 25:5405-5413.
24. Berry C.C., Wells S., Charles S., Curtis A.S.G. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts invitro. Biomaterials 2003, 24:4551-4557.
25. Moore A., Marecos E., Bogdanov A., Weissleder R. Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology 2000, 214:568-574.
26. Kohler N., Sun C., Fichtenholtz A., Gunn J., Fang C., Zhang M. Methotrexate-immobilized poly (ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery. Small 2006, 2:785-792.
27. Larsen E.K.U., Nielsen T., Wittenborn T., Birkedal H., Vorup-Jensen T., Jakobsen M.H., et al. Size-dependent accumulation of PEGylated silane-coated magnetic iron oxide nanoparticles in murine tumors. ACS Nano 2009, 3:1947-1951.
28. 4 nanoparticles for reduced non-specific uptake by macrophage cells. Adv Mater 2007, 19:3163-3166.
29. 4 superparamagnetic nanocomposite: synthesis and application as a new sorbent for solid-phase extraction. Anal Chim Acta 2013, 68-74.
30. 4 nanoparticle-carbon-nanotube composite and its application in electrochemical biosensing. Small 2008, 4:462-466.
31. Masotti A., Pitta A., Ortaggi G., Corti M., Innocenti C., Lascialfari A., et al. Synthesis and characterization of polyethylenimine-based iron oxide composites as novel contrast agents for MRI. Magn Reson Mat Phys Biol Med 2009, 22:77-87.
32. Namgung R., Singha K., Yu M.K., Jon S., Kim Y.S., Ahn Y., et al. Hybrid superparamagnetic iron oxide nanoparticle-branched polyethylenimine magnetoplexes for gene transfection of vascular endothelial cells. Biomaterials 2010, 31:4204-4213.
33. 4-mesoporous silica yolk-shell nanocapsules for siRNA delivery. Chem Commun 2012, 48:8706-8708.
34. 4 at Au composite nanoparticles for dual mode MR/CT imaging applications. ACS Appl Mater Interfaces 2013, 5:10357-10366.
35. Chen K., Xie J., Xu H., Behera D., Michalski M.H., Biswal S., et al. Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting. Biomaterials 2009, 30:6912-6919.
36. Yoo M.K., Kim I.Y., Kim E.M., Jeong H.-J., Lee C.-M., Jeong Y.Y., et al. Superparamagnetic iron oxide nanoparticles coated with galactose-carrying polymer for hepatocyte targeting. JBiomed Biotechnol 2007, 2007:94740.
37. Mohapatra S., Mallick S.K., Maiti T.K., Ghosh S.K., Pramanik P. Synthesis of highly stable folic acid conjugated magnetite nanoparticles for targeting cancer cells. Nanotechnology 2007, 18:385102.
38. Sun C., Sze R., Zhang M. Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. JBiomed Mater Res Part A 2006, 78A:550-557.
39. Huh Y.-M., Jun Y.-W., Song H.-T., Kim S., Choi J.-S., Lee J.-H., et al. Invivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. JAm Chem Soc 2005, 127:12387-12391.
40. Sun C., Veiseh O., Gunn J., Fang C., Hansen S., Lee D., et al. Invivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. Small 2008, 4:372-379.
41. Lee Y., Lee H., Kim Y.B., Kim J., Hyeon T., Park H., et al. Bioinspired surface immobilization of hyaluronic acid on monodisperse magnetite nanocrystals for targeted cancer imaging. Adv Mater 2008, 20:4154-4157.
42. Bae K.H., Yoon J.J., Park T.G. Fabrication of hyaluronic acid hydrogel beads for cell encapsulation. Biotechnol Prog 2006, 22:297-302.
43. Jiang G., Park K., Kim J., Kim K.S., Oh E.J., Kang H., et al. Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA. Biopolymers 2008, 89:635-642.
44. Kamat M., El-Boubbou K., Zhu D.C., Lansdell T., Lu X., Li W., et al. Hyaluronic acid immobilized magnetic nanoparticles for active targeting and imaging of macrophages. Bioconjugate Chem 2010, 21:2128-2135.
45. Yu M., Jambhrunkar S., Thorn P., Chen J., Gu W., Yu C. Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells. Nanoscale 2013, 5:178-183.
46. Toole B.P., Wight T.N., Tammi M.I. Hyaluronan-cell interactions in cancer and vascular disease. JBiol Chem 2002, 277:4593-4596.
47. El-Dakdouki M.H., El-Boubbou K., Kamat M., Huang R., Abela G.S., Kiupel M., et al. CD44 targeting magnetic glyconanoparticles for atherosclerotic plaque imaging. Pharm Res 2013, 10.1007/s11095-013-1021-8.
48. 4 nanocrystals. Nanoscale Res Lett 2013, 8:1-9.
49. Lee D.-E., Kim A.Y., Saravanakumar G., Koo H., Kwon I.C., Choi K., et al. Hyaluronidase-sensitive SPIONs for MR/optical dual imaging nanoprobes. Macromol Res 2011, 19:861-867.
50. Lee H., Mok H., Lee S., Oh Y.-K., Park T.G. Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. JControl Release 2007, 119:245-252.
51. Wei X., Senanayake T.H., Warren G., Vinogradov S.V. Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors. Bioconjugate Chem 2013, 24:658-668.
52. Lee H., Ahn C.-H., Park T.G. Poly[lactic-co-(glycolic acid)]-grafted hyaluronic acid copolymer micelle nanoparticles for target-specific delivery of doxorubicin. Macromol Biosci 2009, 9:336-342.
53. El-Dakdouki M.H., Zhu D.C., El-Boubbou K., Kamat M., Chen J., Li W., et al. Development of multifunctional hyaluronan-coated nanoparticles for imaging and drug delivery to cancer cells. Biomacromolecules 2012, 13:1144-1151.
54. Cai H., An X., Cui J., Li J., Wen S., Li K., et al. Facile hydrothermal synthesis and surface functionalization of polyethyleneimine-coated iron oxide nanoparticles for biomedical applications. ACS Appl Mater Interfaces 2013, 5:1722-1731.
55. Li J., Zheng L., Cai H., Sun W., Shen M., Zhang G., et al. Polyethyleneimine-mediated synthesis of folic acid-targeted iron oxide nanoparticles for invivo tumor MR imaging. Biomaterials 2013, 34:8382-8392.
56. Shen M., Cai H., Wang X., Cao X., Li K., Wang S.H., et al. Facile one-pot preparation, surface functionalization, and toxicity assay of APTS-coated iron oxide nanoparticles. Nanotechnology 2012, 23:105601.
57. Ma M., Chen H., Chen Y., Zhang K., Wang X., Cui X., et al. Hyaluronic acid-conjugated mesoporous silica nanoparticles: excellent colloidal dispersity in physiological fluids and targeting efficacy. JMater Chem 2012, 22:5615-5621.
58. Li F., Park S.-J., Ling D., Park W., Han J.Y., Na K., et al. Hyaluronic acid-conjugated graphene oxide/photosensitizer nanohybrids for cancer targeted photodynamic therapy. JMater Chem B 2013, 1:1678-1686.
59. Cho H.-J., Yoon H.Y., Koo H., Ko S.-H., Shim J.-S., Cho J.-H., et al. Hyaluronic acid-ceramide-based optical/MR dual imaging nanoprobe for cancer diagnosis. JControl Release 2012, 162:111-118.
60. Wang S., Wu Y., Guo R., Huang Y., Wen S., Shen M., et al. Laponite nanodisks as an efficient platform for doxorubicin delivery to cancer cells. Langmuir 2013, 29:5030-5036.
61. Wen S., Liu H., Cai H., Shen M., Shi X. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes. Adv Healthcare Mater 2013, 2:1267-1276.
62. Wang Y., Guo R., Cao X., Shen M., Shi X. Encapsulation of 2-methoxyestradiol within multifunctional poly(amidoamine) dendrimers for targeted cancer therapy. Biomaterials 2011, 32:3322-3329.
63. Zhang M., Guo R., Wang Y., Cao X., Shen M., Shi X. Multifunctional dendrimer/combretastatin A4 inclusion complexes enable invitro targeted cancer therapy. Int J Nanomed 2011, 6:2337-2349.
64. Choi K.Y., Min K.H., Na J.H., Choi K., Kim K., Park J.H., et al. Self-assembled hyaluronic acid nanoparticles as a potential drug carrier for cancer therapy: synthesis, characterization, and invivo biodistribution. JMater Chem 2009, 19:4102-4107.
65. Liu H., Xu Y., Wen S., Chen Q., Zheng L., Shen M., et al. Targeted tumor computed tomography imaging using low-generation dendrimer-stabilized gold nanoparticles. Chem Eur J 2013, 19:6409-6416.
66. Liu H., Xu Y., Wen S., Zhu J., Zheng L., Shen M., et al. Facile hydrothermal synthesis of low generation dendrimer-stabilized gold nanoparticles for invivo computed tomography imaging applications. Polym Chem 2013, 4:1788-1795.
67. Arpicco S., Lerda C., Dalla Pozza E., Costanzo C., Tsapis N., Stella B., et al. Hyaluronic acid-coated liposomes for active targeting of gemcitabine. Eur J Pharm Biopharm 2013, 85:373-380.
68. Yang H., Zhang C., Shi X., Hu H., Du X., Fang Y., et al. Water-soluble superparamagnetic manganese ferrite nanoparticles for magnetic resonance imaging. Biomaterials 2010, 31:3667-3673.
69. Kumar R., Roy I., Ohulchanskky T.Y., Vathy L.A., Bergey E.J., Sajjad M., et al. Invivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano 2010, 4:699-708.
70. Wang H., Zheng L., Peng C., Shen M., Shi X., Zhang G. Folic acid-modified dendrimer-entrapped gold nanoparticles as nanoprobes for targeted CT imaging of human lung adencarcinoma. Biomaterials 2013, 34:470-480.
71. Peng C., Qin J., Zhou B., Chen Q., Shen M., Zhu M., et al. Targeted tumor CT imaging using folic acid-modified PEGylated dendrimer-entrapped gold nanoparticles. Polym Chem 2013, 4:4412-4424.